MNG
MDT icon

Manning & Napier Group’s Medtronic MDT Stock Holding History

Manning & Napier Group’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$116M Sell
1,332,282
-201,728
-13% -$17.2M 1.33% 21
2023
Q4 		$126M Sell
1,534,010
-785,820
-34% -$59.9M 1.5% 18
2023
Q3 		$182M Buy
2,319,830
+6,497
+0.3% +$544K 2.25% 8
2023
Q2 		$204M Buy
2,313,333
+591,792
+34% +$50.9M 2.33% 6
2023
Q1 		$139M Buy
1,721,541
+236,628
+16% +$19.3M 1.62% 14
2022
Q4 		$115M Sell
1,484,913
-26,429
-2% -$2.14M 1.42% 16
2022
Q3 		$122M Buy
1,511,342
+291
+0% +$26.2K 1.59% 15
2022
Q2 		$136M Buy
1,511,051
+251,436
+20% +$25.5M 1.57% 16
2022
Q1 		$140M Sell
1,259,615
-54,415
-4% -$5.75M 1.33% 17
2021
Q4 		$136M Buy
1,314,030
+8,467
+0.6% +$980K 1.13% 26
2021
Q3 		$164M Buy
1,305,563
+301,019
+30% +$39M 1.4% 15
2021
Q2 		$125M Sell
1,004,544
-377,411
-27% -$47.4M 1.02% 25
2021
Q1 		$163M Buy
1,381,955
+23,033
+2% +$2.7M 1.39% 16
2020
Q4 		$159M Sell
1,358,922
-18,021
-1% -$1.98M 1.48% 15
2020
Q3 		$143M Sell
1,376,943
-14,738
-1% -$1.48M 1.45% 18
2020
Q2 		$128M Sell
1,391,681
-2,136
-0.2% -$205K 1.36% 19
2020
Q1 		$126M Sell
1,393,817
-1,025,125
-42% -$109M 1.48% 19
2019
Q4 		$274M Sell
2,418,942
-684,703
-22% -$75.1M 2.96% 3
2019
Q3 		$337M Sell
3,103,645
-225,499
-7% -$23.5M 3.77% 1
2019
Q2 		$324M Buy
3,329,144
+145,641
+5% +$13.3M 3.52% 1
2019
Q1 		$290M Buy
3,183,503
+13,712
+0.4% +$1.23M 3.17% 2
2018
Q4 		$288M Sell
3,169,791
-269,735
-8% -$25.2M 3.52% 2
2018
Q3 		$338M Sell
3,439,526
-158,311
-4% -$14.6M 3.33% 1
2018
Q2 		$308M Sell
3,597,837
-1,087,108
-23% -$90.8M 3.04% 2
2018
Q1 		$376M Sell
4,684,945
-249,618
-5% -$20.6M 3.69% 1
2017
Q4 		$398M Buy
+4,934,563
New +$395M 3.58% 1

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Manning & Napier Group's MDT Position: Q1 2024 in Review

Manning & Napier Group reduced its Medtronic (MDT) stake by 13% in Q1 2024, selling an estimated $17.2M and leaving 1,332,282 shares worth $116M. The position accounts for 1.33% of the portfolio, ranked #21.

Manning & Napier Group first reported a position in MDT in Q4 2017 and has held it in 26 quarters since. The position peaked at $398M in Q4 2017. 2,081 funds tracked by Wall St. Rank hold MDT as of Q1 2024.

  • Manning & Napier Group held 1,332,282 shares of Medtronic worth $116M as of Q1 2024.
  • Manning & Napier Group sold 201,728 Medtronic shares in Q1 2024, an estimated $17.2M.
  • Medtronic made up 1.33% of Manning & Napier Group's portfolio in Q1 2024, its #21 holding.
  • Manning & Napier Group first reported a position in Medtronic in Q4 2017 and has held it in 26 quarters since.
  • Manning & Napier Group's Medtronic position peaked at $398M in Q4 2017.
  • 2,081 funds tracked by Wall St. Rank held Medtronic as of Q1 2024.

Based on Manning & Napier Group's 13F filing for Q1 2024, filed 15 Apr 2024.